Although that finding was revealed by mutation of the p85 binding sites on PyMT [20], our pathway and protein–protein interaction analyses on the tyrosine-phosphorylated proteins selectively enriched in these tumours also support a key role for PI3 kinase signalling in this tumour type. The gene discussed is PIK3R1; the disease is neoplasm.